GeneCopoeia
GeneCopoeia is a US-based functional genomics company that sells a 140,000+ clone ORF cDNA catalog plus CRISPR, viral delivery, qPCR, and microarray reagents to academic and pharmaceutical researchers worldwide, primarily through its e-commerce site and distributor network.
- Company typePrivate
- Founded1999
- HeadquartersRockville, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What GeneCopoeia does
GeneCopoeia, Inc. is a Rockville, Maryland-based functional genomics company founded in 1999 that develops and manufactures molecular biology reagents and research tools for academic and biopharma laboratories. The company's core offering is the OmicsLink catalog of 140,000+ pre-made, Sanger-verified ORF cDNA clones with genome-wide human and mouse coverage and 200+ vector backbones, supplemented by the Nextday-ORF shipping program. Around this catalog the company has assembled an end-to-end workflow ecosystem spanning GeneHero CRISPR-Cas9 reagents, shRNA and miRNA knockdown tools, lentiviral and AAV viral delivery systems, premade stable cell lines, antigen and peptide microarrays, NGS reference standards (OncoSpot), transfection reagents (EndoFectin), and a qPCR reagent line built on BlazeTaq and SureScript chemistries. Proprietary technologies including AviTag biotinylation and HaloTag protein labeling differentiate portions of the catalog. ISO 9001:2015 certification governs the reference standards manufacturing line.
The business operates as a hybrid catalog and custom services vendor. Catalog items are sold direct-to-customer via e-commerce at unit prices (e.g., Nextday-ORF clones start at $69; reagent kits range from roughly $75 to $2,150) with next-day shipping on fast-moving SKUs and volume discounts on bulk clone sets. Custom services — including cloning, gene synthesis, lentivirus and AAV production, CRISPR sgRNA design, cell line characterization, and microarray profiling — are quote-based, often contracted as multi-year arrangements. Distribution combines direct e-commerce with a worldwide distributor network. Customer segments are split between academic and government researchers running functional genomics studies and pharmaceutical/diagnostic R&D groups requiring reference standards, authenticated cell lines, and viral vectors for preclinical and assay development work. Reported headcount of 1-10 suggests a lean operation relative to catalog breadth, likely supported by outsourced manufacturing and distributor-led international coverage.
GeneCopoeia firmographics
Firmographics- Name
- GeneCopoeia
- Legal name
- GeneCopoeia, Inc.
- Website
- https://genecopoeia.com
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- GeneCopoeia is a US-based functional genomics company that sells a 140,000+ clone ORF cDNA catalog plus CRISPR, viral delivery, qPCR, and microarray reagents to academic and pharmaceutical researchers worldwide, primarily through its e-commerce site and distributor network.
- Ownership category
- akta.pro rank
GeneCopoeia industry classification
Industry- Product category
- Functional Genomics Research Tools
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Gene Therapy Vector Manufacturing & CDMO Services (HLAAACAJ)
- akta.pro secondary industries
- Gene Therapy (Viral Vector/Plasmid) CDMO (HLAGABAE), mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC), Plasmid DNA & mRNA Manufacturing Services (HLAAAKAE)
Keywords
Where GeneCopoeia is headquartered
LocationHeadquarters
- HQ city
- Rockville
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
GeneCopoeia business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- Catalog Products Sales: Sale of pre-made functional genomics products including ORF clones, CRISPR reagents, miRNA tools, viral vectors, cell lines, qPCR reagents, microarrays, and other molecular biology reagents. Products are sold through e-commerce with standard pricing for catalog items.
- Custom Services: Custom services including custom cloning, gene synthesis, lentivirus/AAV production, CRISPR sgRNA design, cell line characterization, antigen microarray profiling, and peptide microarray services. Custom services are quote-based.
- Clone Sets (Bulk Orders): Pre-made or custom-selected ORF clone sets sold in bulk to academic and biopharma customers for large-scale high content and high-throughput screening studies. Discount pricing available for bulk orders.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Nextday-ORF™ Collection - Expression-ready ORF clones |
| Unit Pricing | Pay-as-you-go | All-in-One™ qPCR Mix |
| Unit Pricing | Pay-as-you-go | SureScript™ First-Strand cDNA Synthesis Kit |
| Unit Pricing | Pay-as-you-go | RNAzol® RT RNA Isolation Reagent |
| Unit Pricing | Pay-as-you-go | NileHiFi® Long Amplicon PCR Kit |
| Unit Pricing | Pay-as-you-go | Lenti-Pac™ Lentivirus Concentration Solution |
| Unit Pricing | Pay-as-you-go | EGFR L858R Reference Standard (FFPE) |
| Unit Pricing | Pay-as-you-go | PIK3CA E545K Reference Standard (gDNA) |
| Unit Pricing | Pay-as-you-go | Wild type Parental RKO Reference Standard |
| Other | Multi-year contract | Custom Services |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
GeneCopoeia product offering
Product offeringCore offering
GeneCopoeia manufactures and distributes functional genomics research tools — primarily the OmicsLink Expression-Ready ORF cDNA Clones collection of 140,000+ clones, CRISPR-Cas9 and shRNA genome editing tools, lentiviral and AAV viral delivery systems, stable cell lines, antigen/peptide microarrays, qPCR reagent kits, and NGS reference standards — for academic, government, and biopharma research laboratories. The company also provides quote-based custom services spanning custom cloning, gene synthesis, viral particle production, CRISPR sgRNA design, and cell line characterization.
Product overview
GeneCopoeia is a U.S.-based functional genomics company founded in 1999 that develops and commercializes products for genomics, proteomics, and molecular and cellular biology research. The product portfolio is organized as a multi-platform offering centered around gene expression and manipulation tools. Core products include the OmicsLink Expression-Ready ORF cDNA Clones collection (with over 140,000 clones and next-day shipping), GeneHero CRISPR-Cas9 genome editing tools, shRNA and miRNA expression clones for gene knockdown, luciferase reporter assays and promoter clones, lentiviral and AAV viral delivery systems, stable cell lines, antigen and peptide microarrays, and comprehensive qPCR reagent solutions (BlazeTaq SYBR Green mixes, SureScript cDNA synthesis kits). The company also offers extensive custom services including custom cloning, gene synthesis, viral particle production, cell line characterization, and custom microarray profiling. All ORF clones are Sanger-sequenced and sequence-verified with guaranteed amino acid sequence matching to NCBI database.
Differentiator
Problem solved
Functional benefit
Products and services
- OmicsLink Expression-Ready ORF cDNA Clones Expression-ready ORF cDNA clones with genome-wide human and mouse coverage and over 140,000 premade options across 200+ vector systems, providing validated, sequence-verified open reading frame constructs for functional genomics, protein expression, and gene overexpression studies by academic and biopharma researchers.
- Nextday-ORF Collection Quick-fulfillment subset of OmicsLink ORF clones with guaranteed next-day shipping on 140,000 premade clones, targeting researchers with time-sensitive project timelines who need expression-ready constructs in mammalian, lentiviral, or Gateway vector systems.
- GeneHero CRISPR-Cas9 Products CRISPR-Cas9 genome editing reagent line covering Cas9 nucleases, CRISPRa and CRISPRi stable cell lines, sgRNA libraries, HDR donor clones, TALEN/TAL effectors, and safe-harbor knock-in systems, providing complete CRISPR workflow tools for academic and translational gene-editing laboratories.
- shRNA Expression Clones Premade genome-wide shRNA expression clones for human, mouse, and rat gene knockdown applications, available as sets and individual constructs for functional loss-of-function studies and RNA interference research.
- miRNA Solutions Complete microRNA research toolset including 3' UTR target clones, precursor expression clones, inhibitor expression clones, RT-qPCR kits/primers, and qPCR arrays, supporting miRNA target validation, expression profiling, and functional studies.
- Luciferase Assays and Reporters Dual-luciferase reporter assay kits and promoter reporter clones including Firefly/Renilla Duo-luciferase HS/HT/standard kits, Gaussia luciferase kits, and TRE promoter reporters for gene regulation, signaling pathway, and miRNA target validation studies.
- Lentiviral Delivery Systems Complete lentiviral packaging and delivery line including pre-made lentiviral particles, cell immortalization reagents, lentiviral ORF/shRNA/CRISPR clones, packaging kits, and Lenti-Pac concentration solution, enabling high-titer lentivirus production for gene delivery, stable cell line generation, and gene therapy research.
- AAV Particles Pre-made adeno-associated virus (AAV) particles and AAV clones for in vivo and in vitro gene delivery, with a serotype testing kit to support AAV tropism studies and gene therapy research.
- Stable Cell Lines Premade stable cell lines including Cas9, CRISPRa/i, COVID-19 coronavirus receptor, labeled cancer, CAR-T target luciferase reporter, and cancer mutation biomarker lines, supporting gene editing, immuno-oncology, infectious disease, and cancer research.
- OmicsArray Antigen Microarrays Antigen microarray panels for autoantibody detection and biomarker profiling covering autoimmune disease, cancer, infection, allergy, and neurodegenerative disease research applications, supplied as pre-made panels or custom profiling services.
- Peptide Microarrays Pre-made and custom peptide microarray services for antibody epitope mapping, protein-protein interaction studies, and other protein research applications.
- Exosome Solutions Exosome research workflow including isolation kits, RT-qPCR kits, miRNA qPCR arrays, and exosome-labeling lentivirus particles for biomarker discovery and extracellular vesicle research.
- qPCR Products Complete qPCR reagent portfolio including CytoCt RT-qPCR kits, BlazeTaq SYBR Green mixes, All-in-One mixes, one-step RT-qPCR kits, first-strand cDNA synthesis kits, miRNA qPCR kits, and gene/miRNA qPCR arrays for gene expression quantification.
- EndoFectin Transfection Reagents Lipid-based transfection reagent family including EndoFectin Max, EndoFectin Lenti, EndoFectin Expi293, EndoFectin RNAi, CRISPR-Fectin, and EndoFectin HepG2 for plasmid, lentivirus packaging, protein production, RNAi, CRISPR, and liver cell transfection workflows.
- IVT RNA Synthesis Products In vitro transcription (IVT) reagent line including T7 RNA Polymerase, T7 RNA Synthesis Kit, Poly(A) Polymerase, and DNase I for mRNA synthesis, RNA biology, and vaccine research applications.
- OncoSpot NGS Reference Standards Biological reference standards with defined mutations such as EGFR L858R, KRAS G12C/D, NRAS G12D, PIK3CA E545K, and wild-type controls, supplied in cell line-derived gDNA and FFPE formats manufactured under ISO 9001:2015 quality systems for validating Sanger sequencing, qPCR, and NGS assays in genetic testing and diagnostic development.
- FISH Probes Chromosome enumeration and disease-gene fluorescence in situ hybridization (FISH) probes for detection of oncogene deletion, amplification, and rearrangement in cytogenetics and cancer research.
- Cell Line Characterization Services Quote-based custom laboratory services for cell line authentication and characterization, including STR analysis, microsatellite instability (MSI) analysis, mycoplasma detection, FISH analysis, and transcriptome profiling for research and quality control.
- Custom Cloning Services Quote-based custom cloning service for constructing ORF cDNAs, gene reporters, miRNA 3' UTR targets, shRNA clones, and CRISPR constructs in customer-specified vectors.
- Custom Gene Synthesis Services Quote-based de novo gene synthesis service providing custom DNA constructs for genes not already available in the GeneCopoeia catalog.
- Custom Lentivirus Production Services Quote-based custom lentivirus production service for high-titer delivery of customer-specified ORF cDNA, CRISPR sgRNA, shRNA, miRNA precursor, or promoter reporter constructs.
- Custom AAV Production Services Quote-based custom adeno-associated virus (AAV) production service for human and mouse ORFs for in vivo and in vitro gene delivery.
- Clone Sets Pre-made ORF clone sets organized by gene families — including cytokines, CDs, GPCRs, kinases, transcription factors, epigenetics, ion channels, cancer driver genes, immune checkpoint, SARS-CoV-2 host interaction genes, and drug target genes — sold in bulk at up to 90% savings per clone for high-throughput and high-content screening studies.
- OmicsLink Antibody Products OmicsLink antibody product line including anti-tag antibodies (Flag, HA, Myc) for tagged-protein detection, recombinant proteins, and biotin protein ligase enzymes.
Quantifiable outcome
- Over 100 peer-reviewed publications cite GeneCopoeia products annually, validating product quality and research impact
- +3 more outcomes
Companies that use GeneCopoeia
Customer profileSegments2 records
Ideal customer profiles2 records
GeneCopoeia technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature11 records
GeneCopoeia partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights6 records
GeneCopoeia competitors and assessment
Company assessmentDirect peers
- Applied Biological Materials (abm): Canadian molecular biology tools company offering ORF clones, viral vectors (lentivirus, AAV, adenovirus), CRISPR reagents, and cell lines. Direct competitor in catalog ORF clones, viral delivery systems, and CRISPR genome editing tools.
- Addgene: Non-profit plasmid repository distributing tens of thousands of plasmids including ORF clones, CRISPR vectors, and viral vectors to academic researchers globally. Direct competitor to GeneCopoeia's catalog ORF clone and viral vector business, with comparable product categories and overlapping academic customer base.
- GenScript: Global life science tools company offering gene synthesis, ORF clones, CRISPR reagents, viral vectors, and custom services. Direct competitor across GeneCopoeia's catalog and custom service lines, with substantially larger scale and global commercial footprint.
- OriGene Technologies: U.S.-based molecular biology tools company offering ORF cDNA clones, CRISPR reagents, antibodies, and viral vectors. Closely comparable product portfolio and customer segments to GeneCopoeia, including genome-wide human and mouse clone collections and gene family-targeted clone sets.
- VectorBuilder: Commercial viral vector design and manufacturing platform offering custom lentivirus, AAV, and other viral particles with online design tools. Direct competitor to GeneCopoeia's custom lentivirus/AAV production services and viral vector catalog, serving overlapping gene therapy and academic research customers.
Emerging players
- Synthego: CRISPR reagents and cell engineering company offering synthetic sgRNAs, Cas9 nucleases, and engineered cell lines. Emerging competitor with strong positioning in CRISPR reagent categories where it overlaps with GeneCopoeia's GeneHero product line.
Broad incumbents
- Thermo Fisher Scientific (GeneArt / Invitrogen): Global life science tools giant offering GeneArt gene synthesis, Invitrogen ORF clones, viral vectors, CRISPR tools, and qPCR reagents. Broad incumbent competitor with overlapping catalog products and substantially larger R&D, distribution, and commercial resources.
- Revvity (formerly Horizon Discovery): Life science tools provider offering cell line engineering, CRISPR reagents, and reference standards through its Horizon Discovery legacy. Overlaps with GeneCopoeia's stable cell line, CRISPR, and reference standard product categories at much larger scale.
- Twist Bioscience: DNA synthesis company offering gene fragments, ORF clones, antibody libraries, and NGS target enrichment. Comparable to GeneCopoeia in synthetic DNA and clone products, with a public-company balance sheet supporting much faster catalog expansion.
- Integrated DNA Technologies (IDT): Major oligonucleotide and CRISPR reagent manufacturer (Danaher subsidiary) offering sgRNAs, HDR donor oligos, qPCR probes, and gene editing tools. Overlaps with GeneCopoeia's CRISPR, qPCR, and oligo product lines through a much broader portfolio and global commercial scale.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks2 records
Key highlights6 records
Customer concentration
GeneCopoeia social profiles
Digital presenceGeneCopoeia compliance and trust
Trust signalCompliance1 record
GeneCopoeia financial estimates
Financial estimateRevenue estimate
Valuation estimate
GeneCopoeia leadership team
Management profileNumber of profiles
Profiles1 record
GeneCopoeia funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
GeneCopoeia M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about GeneCopoeia
What does GeneCopoeia do?
GeneCopoeia manufactures and distributes functional genomics research tools — primarily the OmicsLink Expression-Ready ORF cDNA Clones collection of 140,000+ clones, CRISPR-Cas9 and shRNA genome editing tools, lentiviral and AAV viral delivery systems, stable cell lines, antigen/peptide microarrays, qPCR reagent kits, and NGS reference standards — for academic, government, and biopharma research laboratories. The company also provides quote-based custom services spanning custom cloning, gene synthesis, viral particle production, CRISPR sgRNA design, and cell line characterization.
Is GeneCopoeia a public or private company?
GeneCopoeia is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was GeneCopoeia founded?
GeneCopoeia was founded in 1999. It employs 1 to 10 people.
Where is GeneCopoeia based?
GeneCopoeia is headquartered in Rockville, United States, in the North America region.
How does GeneCopoeia make money?
Three revenue lines are on record. Catalog Products Sales are the primary driver. The others are custom Services and clone Sets (Bulk Orders).
Who are GeneCopoeia's main competitors?
Direct peers on record are Applied Biological Materials (abm), Addgene, GenScript, OriGene Technologies and VectorBuilder. Synthego is listed as an emerging player. Broad incumbents are Thermo Fisher Scientific (GeneArt / Invitrogen), Revvity (formerly Horizon Discovery), Twist Bioscience and Integrated DNA Technologies (IDT).
Does GeneCopoeia have an API?
No public API is recorded for GeneCopoeia.
What industry is GeneCopoeia in?
GeneCopoeia's product category is Functional Genomics Research Tools. Its primary akta.pro industry code is HLAAACAJ, Gene Therapy Vector Manufacturing & CDMO Services, with a secondary code of HLAGABAE, Gene Therapy (Viral Vector/Plasmid) CDMO. Its NAICS code is 541714 and its SIC code is 8731.